HUTCHMED (China) (HMDCF) Payables (2015 - 2026)
HUTCHMED (China)'s (HMDCF) quarterly Payables came in at $33.6 million in Q2 2026, down 23.05% year-over-year from $43.7 million in Q2 2025, and down 26.11% quarter-over-quarter from $45.5 million in Q4 2025.
Analysis
HUTCHMED (China) (HMDCF) Payables (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Payables for 12 consecutive years, with $33.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Payables fell 23.05% year-over-year to $33.6 million in Q2 2026; TTM through Jun 2026 was $33.6 million, a 23.05% decrease from a year earlier, with the FY2025 full-year figure at $45.5 million, changed N/A from the prior year.
- Payables was $33.6 million for Q2 2026 at HUTCHMED (China), down from $45.5 million in the prior quarter.
- Over five years, Payables peaked at $73.2 million in Q4 2022 and troughed at $33.6 million in Q2 2026.
- A 5-year average of $49.9 million and a median of $45.5 million in 2025 frame the typical range for Payables.
- Across the five-year window, Payables jumped 83.36% in 2022 and dropped 23.23% in 2024, its largest moves.
- Over 5 years, Payables stood at $73.2 million in 2022, then declined by 22.79% to $56.5 million in 2023, then dropped by 23.23% to $43.4 million in 2024, then advanced by 4.92% to $45.5 million in 2025, then fell by 26.11% to $33.6 million in 2026.
- The last three Payables figures came in at $33.6 million (Q2 2026), $45.5 million (Q4 2025), and $43.7 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 210.98 Bn | 196.99 Bn | 7.24 Bn | 2.87 Bn |
| 2 | Gilead Sciences | 181.24 Bn | 178.06 Bn | 6.22 Bn | 674.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.38 Bn | 124.53 Bn | 2.84 Bn | 429.50 Mn |
| 4 | Regeneron Pharmaceuticals | 82.97 Bn | 74.97 Bn | 3.93 Bn | 1.16 Bn |
| 5 | Argenx Se | 61.59 Bn | 56.41 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 54.80 Bn | 49.67 Bn | 52.00 Mn | 167.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.09 Bn | 30.78 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Biogen | 31.34 Bn | 30.05 Bn | 1.96 Bn | 403.90 Mn |
| 9 | Roivant Sciences | 30.11 Bn | 30.11 Bn | 1.16 Mn | 25.08 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | 33.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.65 Mn |
| Dec 31, 2025 | 45.53 Mn |
| Jun 30, 2025 | 43.73 Mn |
| Jun 30, 2024 | 43.40 Mn |
| Jun 30, 2023 | 56.53 Mn |
| Dec 31, 2022 | 73.22 Mn |
| Jun 30, 2022 | 53.07 Mn |
| Dec 31, 2021 | 43.09 Mn |
| Jun 30, 2021 | 28.94 Mn |
| Mar 31, 2021 | 28.64 Mn |
| Dec 31, 2020 | 32.01 Mn |
| Jun 30, 2020 | 25.87 Mn |
| Dec 31, 2019 | 9.71 Mn |
| Sep 30, 2019 | 23.03 Mn |
| Jun 30, 2019 | 26.15 Mn |
| Mar 31, 2019 | 30.76 Mn |
| Dec 31, 2018 | 27.34 Mn |
| Jun 30, 2018 | 30.00 Mn |
| Dec 31, 2017 | 18.81 Mn |
| Jun 30, 2017 | 54.12 Mn |